Fluoroquinolones are broad-spectrum antibiotics with good oral bioavailability. They are used for the treatment of a wide variety of infections, but there are restrictions on prescribing these drugs. Epidemiological studies have reported an increased risk of rare adverse effects. These include tendinopathy and tendon rupture, peripheral neuropathy and aortic aneurysm. Safe prescribing of fluroquinolones requires recognition of patients with risk factors for toxicity. Prompt drug discontinuation is recommended in the event of an adverse reaction. Practising antimicrobial stewardship by prescribing fluoroquinolones only when alternative drugs are unavailable is also key to limiting adverse events and antibiotic resistance.
CITATION STYLE
Baggio, D., & Ananda-Rajah, M. R. (2021). Fluoroquinolone antibiotics and adverse events. Australian Prescriber, 44(5), 161–164. https://doi.org/10.18773/austprescr.2021.035
Mendeley helps you to discover research relevant for your work.